Mumbai, 26 March 2024: Pharma major Lupin Ltd on Friday (March 22) said the company is planning to carve out its trade generics business in India and transfer it to Lupin Life Sciences Ltd (LLSL), a wholly-owned subsidiary of the company, for ₹100-120 crore.

 <......
View Details

Related News

• PIL questioning quality of Anti-Rabies Vaccine disposed of by SC (22-01-2025)

---

• NCB seizes drugs worth more than 14 lakhs in Jaipur, One arrested (21-01-2025)

---

• Trump withdraws US from WHO (21-01-2025)

---

• Telangana Officials Raid Illegal De-Addiction Center in Hanumakonda (21-01-2025)

---

• Major pharmacy benefit managers found by US FTC to have inflated drug prices for a $7.3 billion gain (21-01-2025)

---

• Agra: Child given expired vaccine, doctor said- a mistake happened (21-01-2025)

---

• Police Seize Nearly 1,300 Bottles of Codeine Cough Syrup in Abandoned Vehicle (21-01-2025)

---

• Vaccine sector does not require incentives or breaks but needs relief from rigid price controls: Adar Poonawalla (21-01-2025)

---

• CSIR-IIIM Hosts Groundbreaking Workshop on Herbal Medicine Production (21-01-2025)

---

• 530 Sedative Pills seized from Nalagarh resident (21-01-2025)

---